Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The global gelatine market attained a value of USD 4260.73 Million in 2025 and is projected to expand at a CAGR of 5.50% through 2035. The market is further expected to achieve USD 7277.94 Million by 2035, driven by rising demand for collagen-based nutraceuticals, expanding pharmaceutical capsule and soft-gel production, and continued use of gelatine across bakery, confectionery, and dessert applications worldwide.
Industry estimates place global gelatine demand at roughly 400,000 to 450,000 metric tons annually as of 2025, with demand concentrated across food and beverage, pharmaceutical, and nutraceutical applications. Rising consumption of collagen peptides, gummy vitamins, and soft-gel capsules continues to lift overall volumes, while manufacturers increasingly pursue traceable, non-GMO, and halal-certified sourcing to meet buyer specifications across both mature Western markets and fast-growing Asia Pacific economies, where domestic capacity additions are reshaping regional supply chains.
Capacity investment is accelerating across major producers: Gelita AG's April 2026 expansion of its Liaoyuan, China facility into the company's largest global gelatine production base added a new line with 11,000 tonnes of annual capacity, with plant leadership citing export volumes on track to reach roughly 30% of the site's total 2026 output. Such moves illustrate how established European and Asian producers are scaling capacity to meet food, pharmaceutical, and collagen-peptide demand simultaneously, reinforcing supply resilience as downstream formulators diversify sourcing across geographies.
Consolidation is also reshaping the competitive base: in April 2026, Germany's Bundeskartellamt cleared Darling Ingredients' acquisition of Tessenderlo Group's PB Leiner gelatine and collagen business alongside the formation of Nextida, a combined collagen-peptide venture targeting roughly USD 1.5 billion in annual revenue across 23 facilities on four continents. The clearance signals continued scale-driven integration among the market's largest gelatine and collagen-peptide suppliers as they pursue broader geographic reach and deeper application expertise.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Nitta Gelatin India Ltd, the listed Indian affiliate within the broader Nitta Gelatin group that also includes Nitta Gelatin, NA Inc, disclosed in August 2026 that consolidated net profit for the quarter ended June 2026 rose more than 31% year-on-year, with operating margins expanding on improved production efficiency and firmer pricing for pharmaceutical- and food-grade gelatine. The results point to healthy underlying demand across the group's gelatine and collagen peptide lines. Companies can leverage similar efficiency gains and premium-grade capacity to strengthen margins as downstream pharmaceutical and nutraceutical demand continues to build.
In May 2026, SAS Gelatines Weishardt introduced a new ultra-low molecular weight collagen peptide designed for enhanced absorption, extending the Graulhet, France-based producer's ingredient range for the nutraceutical and beauty-from-within supplement markets. The launch targets formulators seeking faster-absorbing collagen for drinkable and gummy supplement formats, a segment that has grown rapidly alongside broader demand for joint-health and skin-health products. Companies can leverage differentiated molecular-weight collagen platforms to secure premium positioning in the fast-growing nutraceutical supplement category.
Kraft Heinz Co. launched Jell-O Simply in May 2026, a ready-to-eat gelatine dessert line formulated with fruit and vegetable juice colorants, turmeric-root extract, and at least 25% less sugar than standard Jell-O, with flavors including orange, raspberry lemonade, and blueberry. The company has signaled plans to extend the line into pudding and additional gelatine mix formats later in 2026, reflecting continued reliance on gelatine as the functional base even as recipes shift toward cleaner-label ingredient positioning. Companies can leverage clean-label reformulation of classic gelatine desserts to defend shelf space against newer snacking formats.
Germany's Bundeskartellamt cleared Darling Ingredients' acquisition of Tessenderlo Group's PB Leiner gelatine and collagen business in April 2026, alongside the formation of Nextida, a jointly held collagen-peptide venture combining Rousselot BV's platform with PB Leiner's operations across 23 facilities on four continents. Darling Ingredients' leadership described collagen as its fastest-growing food-ingredients business, with the combined venture targeting roughly USD 1.5 billion in annual revenue. Companies can leverage joint ventures of this kind to expand production footprint and application depth without committing fresh capital outright.
Gelita AG's Liaoyuan facility in Jilin province has grown from a single production line in 2006 into the company's largest global gelatine manufacturing base, with a new production line commissioned in April 2026 adding 11,000 tonnes of annual capacity for pharmaceutical-grade gelatine, food-grade gelatine, and functional collagen peptides. Plant leadership has indicated that export volumes are on track to reach roughly 30% of the facility's total production in 2026, reflecting rising overseas demand for Chinese-manufactured gelatine. Companies can leverage large, fully automated production bases to serve both domestic and export pharmaceutical and food-grade demand cost-effectively.
Tessenderlo Group's PB Leiner business is being folded into Nextida, a new collagen-peptide venture formed alongside Darling Ingredients following German antitrust clearance in April 2026, with Tessenderlo retaining a 15% stake against Darling Ingredients' 85%. The combined entity will operate 23 facilities across South America, North America, Europe, and Asia, pursuing roughly USD 1.5 billion in annual revenue without requiring fresh capital investment from either party. The move consolidates PB Leiner's gelatine and collagen know-how with a larger international peptide platform. Companies can leverage capital-light joint ventures to scale collagen and gelatine capacity while sharing technical expertise across partners.
Kraft Heinz Co. introduced Jell-O Simply in May 2026, replacing synthetic dyes with vegetable juice, fruit juice, and turmeric-root extract while cutting sugar content by at least 25% versus the standard recipe, with the gelatine-based dessert priced at roughly a $0.46 premium per four-pack over the original line. The company has outlined plans to broaden the range into pudding and additional gelatine mix varieties later in 2026. The reformulation keeps gelatine as the core functional ingredient while addressing consumer demand for cleaner ingredient labels. Companies can leverage clean-label relaunches of legacy gelatine products to retain shelf space against newer snack and dessert entrants.
Capsule manufacturer ACG announced in October 2025 a phased $200 million investment in its first US empty-capsule facility, with an initial $100 million allocated to a hard-shell plant in Atlanta, Georgia capable of producing both gelatine and HPMC vegetarian capsules, and the remaining $100 million supporting additional regional capacity. Production is slated to begin in early 2027 and is expected to create more than 200 jobs, strengthening North American supply security for pharmaceutical and nutraceutical capsule customers. Companies can leverage regional capsule manufacturing investments to shorten lead times and de-risk gelatine-based supply chains for pharmaceutical customers.
This Expert Market Research Report titled "Global Gelatine Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Raw Material
Key Insight: Pig Skin remains the leading raw material given its wide availability and cost efficiency, a scale reinforced by large hog-processing-region capacity such as Gelita AG's April 2026 expansion of its Liaoyuan, China gelatine base; Bovine Hides is the second-largest source, valued for consistent gel strength in food and pharmaceutical applications; Bone-derived gelatine continues to serve industrial and lower-cost food uses; and Others, spanning fish, poultry, and alternative-sourced gelatine, is growing fastest as halal- and kosher-certified, allergen-declarable formulations gain traction with pharmaceutical and nutraceutical formulators seeking non-bovine, non-porcine sourcing flexibility.
Market Breakup by End Use
Key Insight: Food and Beverages is the leading end-use segment, underpinned by continued reliance on gelatine in classic dessert formats such as Kraft Heinz Co.'s May 2026 relaunch of Jell-O Simply with natural colorants and reduced sugar; Pharmaceuticals and Nutraceuticals is the fastest-growing segment, supported by capacity investments such as ACG's October 2025 commitment of USD 200 million to a new US hard-shell and HPMC capsule facility and by collagen-peptide launches such as SAS Gelatines Weishardt's May 2026 ultra-low molecular weight collagen; Photography is a legacy, low-volume application that persists alongside a modest revival in analog film demand; Cosmetics uses gelatine-derived collagen in topical and beauty-from-within formulations; and Others covers smaller industrial and specialty uses.
Market Breakup by Region
Key Insight: Europe is the leading regional market, anchored by a dense base of long-established gelatine and collagen-peptide producers headquartered in the region; Asia Pacific is the fastest-growing region, driven by capacity expansions such as Gelita AG's April 2026 Liaoyuan, China production base; North America and Latin America continue to grow steadily on pharmaceutical and food-grade demand; and the Middle East and Africa represents a smaller but expanding base as halal-certified gelatine sourcing gains importance.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By Raw Material, Pig Skin leads the market while Others grows fastest because halal- and allergen-flexible sourcing is becoming a key purchasing criterion across pharmaceutical and nutraceutical formulators
Pig Skin-derived gelatine continues to lead the Raw Material segmentation on the back of consistent supply from large-scale pork processing operations and well-established extraction infrastructure across Europe and Asia. Producers such as Gelita AG, which in April 2026 expanded its Liaoyuan, China facility into its largest global gelatine production base with an additional 11,000 tonnes of annual capacity, illustrate how established manufacturers continue to scale pig-skin-compatible processing lines to serve both food-grade and pharmaceutical-grade customers across multiple regions simultaneously.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Others, which includes fish, poultry, and alternative-sourced gelatine, is the fastest-growing raw-material category as buyers increasingly specify halal-certified, kosher-certified, and allergen-declarable sourcing. Capsule and nutraceutical formulators in particular are prioritizing non-bovine, non-porcine gelatine options to serve broader consumer bases, a shift reinforced by capacity commitments such as ACG's October 2025 pledge of USD 200 million toward new US hard-shell and HPMC capsule manufacturing that explicitly supports both gelatine and vegetarian capsule formats.
By End Use, Food and Beverages leads the market while Pharmaceuticals and Nutraceuticals grows fastest because collagen-peptide and capsule demand continues to outpace traditional dessert and confectionery applications
Food and Beverages remains the largest end-use segment for gelatine, reflecting its continued role as a functional base in desserts, confectionery, and dairy products. Kraft Heinz Co.'s May 2026 introduction of Jell-O Simply, a reformulated gelatine dessert line using fruit and vegetable juice colorants and at least 25% less sugar than the standard recipe, demonstrates how legacy food brands continue to rely on gelatine while adapting recipes to current clean-label and reduced-sugar consumer preferences.
Pharmaceuticals and Nutraceuticals is the fastest-growing end-use segment as capsule, soft-gel, and collagen-peptide demand accelerates. Nitta Gelatin India Ltd, part of the broader Nitta Gelatin group that also includes Nitta Gelatin, NA Inc, disclosed in August 2026 that consolidated net profit for the quarter ended June 2026 rose more than 31% year-on-year on firmer pharmaceutical- and nutraceutical-grade gelatine pricing, underscoring the segment's outsized contribution to overall industry profitability and growth.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Europe commands the largest share of the global gelatine market, at approximately 32% in 2025, supported by a dense base of established gelatine and collagen-peptide producers and by steady regional demand from food, pharmaceutical, and nutraceutical manufacturers
This is supported by Germany's Bundeskartellamt, which in April 2026 cleared Darling Ingredients' acquisition of Tessenderlo Group's PB Leiner gelatine and collagen business and the formation of Nextida, a combined collagen-peptide venture spanning facilities across Europe and beyond, underscoring the scale and consolidation of gelatine production rooted in the region.
Asia Pacific is the fastest-growing regional market, led by capacity expansions such as Gelita AG's April 2026 commissioning of a new production line at its Liaoyuan, China facility, which added 11,000 tonnes of annual capacity and positioned the site as the company's largest global gelatine production base. North America and Latin America continue to grow steadily on pharmaceutical and food-grade demand, while the Middle East and Africa remains a smaller but expanding market as halal-certified gelatine sourcing gains importance across the region.
The global gelatine market is moderately consolidated, with a small number of large, vertically integrated producers accounting for a substantial share of global capacity alongside numerous regional and specialty manufacturers serving food, pharmaceutical, and industrial customers.
Competitive dynamics are increasingly shaped by scale-driven consolidation, deeper investment in pharmaceutical-grade and collagen-peptide capacity, and growing emphasis on halal-certified, traceable, and allergen-declarable sourcing, as producers seek to differentiate beyond commodity-grade gelatine and strengthen long-term relationships with food, pharmaceutical, and nutraceutical formulators.
Founded in 1875 and headquartered in Eberbach, Germany, Gelita AG is one of the world's largest gelatine and collagen peptide producers, supplying food, pharmaceutical, nutraceutical, and technical-grade gelatine globally. In April 2026, the company expanded its Liaoyuan, China facility into its largest global gelatine production base, adding a new line with 11,000 tonnes of annual capacity and targeting export volumes of roughly 30% of the site's total 2026 output.
Founded in 1839 and headquartered in Graulhet, France, SAS Gelatines Weishardt is a long-established, family-controlled producer of gelatine and marine collagen for food, nutraceutical, and pharmaceutical applications. In May 2026, the company launched an ultra-low molecular weight collagen peptide designed for enhanced absorption, extending its ingredient range for the fast-growing beauty-from-within and joint-health supplement markets.
Established in 1979 and headquartered in Morrisville, North Carolina, Nitta Gelatin, NA Inc is the North American arm of the Nitta Gelatin group, whose origins trace back to a gelatin and glue manufacturing business founded in Osaka, Japan in the early twentieth century. In August 2026, the group's listed Indian affiliate, Nitta Gelatin India Ltd, disclosed that consolidated net profit for the quarter ended June 2026 rose more than 31% year-on-year, reflecting margin gains across the group's gelatine and collagen peptide operations.
Tracing its origins to a gelatine business established in France in the 1890s, Rousselot BV operates as Darling Ingredients' global gelatine and collagen peptide platform, with production facilities spanning multiple continents including a long-standing site in Ghent, Belgium. In April 2026, Germany's Bundeskartellamt cleared a transaction combining Rousselot's platform with Tessenderlo Group's PB Leiner business into Nextida, a jointly held venture targeting roughly USD 1.5 billion in annual revenue across 23 facilities on four continents.
Other key players in the gelatine market include PB Leiner, among others.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
For a detailed assessment of opportunities across the gelatine market's raw material, end-use, and regional segments through 2026 and beyond, connect with Expert Market Research for a customized consultation.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
The global gelatine market attained a value of USD 4260.73 Million in 2025.
The gelatine market is projected to grow at a CAGR of 5.50% from 2026 to 2035.
The market is estimated to witness healthy growth in the forecast period of 2026-2035 to reach a value of around USD 7277.94 Million by 2035.
Key strategies include capacity expansion in high-growth regions such as Asia Pacific, consolidation through joint ventures and acquisitions to build integrated collagen-peptide platforms, and product innovation in specialty collagen peptides and alternative-sourced gelatine to address evolving pharmaceutical, nutraceutical, and food-industry requirements.
The rising research and development activities are significantly aiding the growth of the market.
North America, Latin America, Middle East and Africa, Europe, and the Asia Pacific are the major regions in the market.
The raw materials for the product include pig skin, bovine hides, and bone, among others.
The product finds extensive end-uses in food and beverage, pharmaceuticals and nutraceuticals, photography, and cosmetics, among others.
Key players in the gelatine market include Gelita AG, SAS Gelatines Weishardt, Nitta Gelatin, NA Inc, Rousselot BV, and PB Leiner, among others.
Key challenges include volatility in raw hide and bone supply linked to livestock processing cycles, rising competition from plant-based and synthetic alternatives in certain applications, and the need to meet increasingly specific halal, kosher, and allergen-declaration requirements from pharmaceutical and food customers.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Raw Material |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 2,499
USD 2,249
tax inclusive*
Single User License
One User
USD 3,999
USD 3,599
tax inclusive*
Five User License
Five User
USD 4,999
USD 4,249
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.